Yunji Soars on Narrower Loss; Ginkgo Bioworks, Xcel Energy Downgraded
- June 02nd, 2023
- 329 views
Yunji Inc. (Nasdaq: YJ) experienced a significant surge in its stock price as the company reported a narrower loss in its financial results.
In the first quarter of 2023, Yunji recorded a net loss of RMB22.9 million (US$3.3 million), representing a substantial improvement of 37.9% compared to the net loss of RMB36.9 million in the same period of the previous year.
$YJ was trading at $0.40 in pre-market, up $0.18 (+88.59%)
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) faced a downgrade in its rating from Neutral to Sell by Goldman Sachs, accompanied by a significant decrease in its price target from $3 to $1.25.
During pre-market, $DNA was trading at $1.60, down $0.07 (-4.46%).
Similarly, Xcel Energy Inc. (Nasdaq: XEL) experienced a downgrade in its rating from Overweight to Neutral by JP Morgan, along with a lowered price target from $79 to $68. Wolfe Research also downgraded XEL from Outperform to Peer Perform.
$XEL was trading at $62.18 in pre-market, showing a decrease of $1.37 (-2.16%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login